292 related articles for article (PubMed ID: 11689445)
21. Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways.
Yue W; Wang JP; Conaway MR; Li Y; Santen RJ
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):265-74. PubMed ID: 14623520
[TBL] [Abstract][Full Text] [Related]
22. TRAF6 and C-SRC induce synergistic AP-1 activation via PI3-kinase-AKT-JNK pathway.
Funakoshi-Tago M; Tago K; Sonoda Y; Tominaga S; Kasahara T
Eur J Biochem; 2003 Mar; 270(6):1257-68. PubMed ID: 12631284
[TBL] [Abstract][Full Text] [Related]
23. Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells.
Duan R; Xie W; Li X; McDougal A; Safe S
Biochem Biophys Res Commun; 2002 Jun; 294(2):384-94. PubMed ID: 12051724
[TBL] [Abstract][Full Text] [Related]
24. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.
Varma H; Conrad SE
Cancer Res; 2002 Jul; 62(14):3985-91. PubMed ID: 12124331
[TBL] [Abstract][Full Text] [Related]
25. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.
Hamelers IH; van Schaik RF; van Teeffelen HA; Sussenbach JS; Steenbergh PH
Exp Cell Res; 2002 Feb; 273(1):107-17. PubMed ID: 11795951
[TBL] [Abstract][Full Text] [Related]
26. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells.
Haynes MP; Sinha D; Russell KS; Collinge M; Fulton D; Morales-Ruiz M; Sessa WC; Bender JR
Circ Res; 2000 Oct; 87(8):677-82. PubMed ID: 11029403
[TBL] [Abstract][Full Text] [Related]
27. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
28. Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO).
Jücker M; Südel K; Horn S; Sickel M; Wegner W; Fiedler W; Feldman RA
Leukemia; 2002 May; 16(5):894-901. PubMed ID: 11986952
[TBL] [Abstract][Full Text] [Related]
29. c-Src-null mice exhibit defects in normal mammary gland development and ERalpha signaling.
Kim H; Laing M; Muller W
Oncogene; 2005 Aug; 24(36):5629-36. PubMed ID: 16007215
[TBL] [Abstract][Full Text] [Related]
30. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.
Mirza AM; Gysin S; Malek N; Nakayama K; Roberts JM; McMahon M
Mol Cell Biol; 2004 Dec; 24(24):10868-81. PubMed ID: 15572689
[TBL] [Abstract][Full Text] [Related]
31. ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases.
Krieg T; Qin Q; McIntosh EC; Cohen MV; Downey JM
Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2322-30. PubMed ID: 12388234
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts.
Takuwa N; Fukui Y; Takuwa Y
Mol Cell Biol; 1999 Feb; 19(2):1346-58. PubMed ID: 9891068
[TBL] [Abstract][Full Text] [Related]
33. AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factor-like domain-dependent manner.
Felekkis KN; Narsimhan RP; Near R; Castro AF; Zheng Y; Quilliam LA; Lerner A
Mol Cancer Res; 2005 Jan; 3(1):32-41. PubMed ID: 15671247
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
[TBL] [Abstract][Full Text] [Related]
35. TIMP-1 inhibits apoptosis in breast carcinoma cells via a pathway involving pertussis toxin-sensitive G protein and c-Src.
Lee SJ; Yoo HJ; Bae YS; Kim HJ; Lee ST
Biochem Biophys Res Commun; 2003 Dec; 312(4):1196-201. PubMed ID: 14652000
[TBL] [Abstract][Full Text] [Related]
36. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells.
Zagozdzon R; Bougeret C; Fu Y; Avraham HK
Int J Oncol; 2002 Dec; 21(6):1347-52. PubMed ID: 12429987
[TBL] [Abstract][Full Text] [Related]
38. Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways.
Wu K; Wang C; D'Amico M; Lee RJ; Albanese C; Pestell RG; Mani S
Mol Cancer Ther; 2002 Jul; 1(9):695-706. PubMed ID: 12479366
[TBL] [Abstract][Full Text] [Related]
39. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
40. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
